HEARS Neuropsychiatric Symptoms & Hearing Loss: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms

Status: Recruiting
Location: See location...
Intervention Type: Behavioral, Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This randomized controlled trial study aims to evaluate a revised hearing care intervention for older adults with Alzheimer's Disease and Related Dementias (ADRD). The community-delivered hearing care intervention utilizes tailored strategies to assess impact on communication, neuropsychiatric symptoms (NPS), and care partner distress.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 60
Maximum Age: 100
Healthy Volunteers: t
View:

• Age 60 - 100 years old

• English-speaking

• Diagnosis of probable Alzheimer's Disease or other related dementia according to the core clinical criteria outlined in the National Institute on Aging (NIA) and Alzheimer's Association Guidelines

• Speech frequency pure tone average (0.5- 4 kHz) \>25 db in the better-hearing ear; adult onset hearing loss

• Availability of caregiver/study partner who is 18+ to participate in all study-related visits and who provides care supervision

• Stable (for 2 weeks or longer) dosing of medication (e.g. antidepressants, antipsychotics) for neuropsychiatric symptoms

Locations
United States
Maryland
Johns Hopkins Memory and Alzheimer's Treatment Center
RECRUITING
Baltimore
Contact Information
Primary
Esther Oh, MD, Ph.D.
eoh9@jhmi.edu
410-550-0925
Backup
Jami Trumbo, MSPH
jami.trumbo@jhu.edu
Time Frame
Start Date: 2025-10-15
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 300
Treatments
Experimental: Immediate treatment
Placebo_comparator: Delayed treatment
Sponsors
Collaborators: National Institute on Aging (NIA)
Leads: Johns Hopkins University

This content was sourced from clinicaltrials.gov